-
-
-
-
-
-
-
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
-
-
-
-
-
-
-
Abeona Therapeutics (ABEO) Receives FDA Complete Response Letter on Pz-cel
-
-
-
-
-
-
-
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
-
-
-
-
-
-
-
Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program in Infantile Batten Disease
-
-
-
-
-
-
15,923 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


